Clinical Trials Directory

Trials / Completed

CompletedNCT01952184

Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.

Oocyte Survival After Vitrification in an Open or Closed Commercial Device: Study on Sibling Donor Oocytes.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Universitair Ziekenhuis Brussel · Academic / Other
Sex
Female
Age
18 Years – 36 Years
Healthy volunteers
Accepted

Summary

The survival rate (and embryo quality) of donor oocytes with two commercially available devices.

Detailed description

Donor sibling oocytes will be vitrified with two commercially available devices. The first device is closed vitrification with closed storage and the second device is open vitrification with closed storage. Oocyte acceptors receive oocytes from both devices. With the increase in cooling rate generated by the open vitrification (second device), we expect to get an increase in survival rate of 10%. Besides this, embryo quality will be assessed with oocytes obtained from both devices.

Conditions

Interventions

TypeNameDescription
DEVICECBSvit HS deviceclosed vitrification with closed storage
DEVICECryotop SC deviceopen vitrification with closed storage

Timeline

Start date
2013-09-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2013-09-27
Last updated
2015-12-03

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01952184. Inclusion in this directory is not an endorsement.

Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage. (NCT01952184) · Clinical Trials Directory